Notably, whole-exome sequencing in a cohort of HNSCC patients showed that 30.5% of HNSCC tumors contained mutations in the PI3K-Akt-mTOR pathway, mostly in Pik3ca, Pik3cg, and Pten [15]. This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.